The time to self-reported recovery was a median of two days faster among the ivermectin recipients, according to the large UK study. The quicker recovery period was statistically significant.

People who received ivermectin were also less likely to be hospitalized or die, with 1.6 percent of ivermectin recipients being hospitalized or dying versus 4 percent of the comparison group, which received typical care, which in the UK is largely focused on managing symptoms.

Ivermectin recipients also enjoyed a reduction of severe symptoms and sustained recovery, according to the study.

https://www.zerohedge.com/markets/people-who-received-ivermectin-were-better-study-finds

AND

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

https://www.journalofinfection.com/article/S0163-4453(24)00064-1/fulltext